Literature DB >> 11686539

Short-term effects of surgery in post-menopausal patients with primary hyperparathyroidism and normal bone turnover.

V Carnevale1, M T Pacitti, M Pileri, F Paglia, A Scillitani, S Dionisi, P Caravella, E Romagnoli, S Minisola.   

Abstract

The most common clinical presentation of primary hyperparathyroidism (PHPT) is nowadays characterized by a slight skeletal involvement. We studied 5 consecutive female patients with PHPT presenting with bone turnover marker levels within the reference range of our Center and whose bone mineral density values were above the usual fracture risk threshold. In each patient we measured, both in basal conditions and daily, for the first 5 days after surgery, the following indexes: serum total (T-ALP) and bone-specific (B-ALP) alkaline phosphatase activity, osteocalcin (BGP, by two different assays), together with the 24-hour urinary excretions of total pyridinoline (Pyr/Cr) and deoxypyridinoline (DPyr/Cr), free deoxypyridinoline (FD-Pyr/Cr), cross-linked N-telopeptide of type I collagen (NTx/Cr), and type I C-telopeptide (CTx/Cr). The markers of both bone formation and resorption significantly decreased after surgery (p<0.001 by multiple ANOVA). Individual post-surgical markers changes were all significant but T-ALP and FD-Pyr, the most pronounced percent reductions being shown by NTx and CTx. The time-course of such variations substantially differed among the various indexes. These results show that bone formation and resorption markers are up-regulated also in PHPT patients with mild skeletal involvement; acute removal of parathyroid hormone excess differently affected the markers of bone turnover in terms of both entity and time-course.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686539     DOI: 10.1007/BF03343897

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.

Authors:  S Valdemarsson; B Lindergård; S Tibblin; A Bergenfelz
Journal:  J Intern Med       Date:  1998-02       Impact factor: 8.989

2.  Clinical validation of a new immunoradiometric assay for intact human osteocalcin.

Authors:  S Minisola; M T Pacitti; E Romagnoli; R Rosso; V Carnevale; P Caravella; A Scillitani; F Dicembrino
Journal:  Calcif Tissue Int       Date:  1999-05       Impact factor: 4.333

3.  The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.

Authors:  S Minisola; M T Pacitti; R Rosso; C Pellegrino; E Ombricolo; D Pisani; E Romagnoli; C Damiani; G Aliberti; A Scarda; S F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

Review 4.  Primary hyperparathyroidism. When to observe and when to operate.

Authors:  J P Bilezikian
Journal:  Endocrinol Metab Clin North Am       Date:  2000-09       Impact factor: 4.741

5.  Age-related changes in the global skeletal uptake of technetium-99m methylene diphosphonate in healthy women.

Authors:  V Carnevale; V Frusciante; A Scillitani; S Modoni; M Pileri; I Chiodini; F Dicembrino; E Romagnoli; S Minisola
Journal:  Eur J Nucl Med       Date:  1996-11

6.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

Review 7.  NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.

Authors: 
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

8.  Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.

Authors:  S P Robins; H Woitge; R Hesley; J Ju; S Seyedin; M J Seibel
Journal:  J Bone Miner Res       Date:  1994-10       Impact factor: 6.741

9.  Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.

Authors:  R J Duda; J F O'Brien; J A Katzmann; J M Peterson; K G Mann; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1988-05       Impact factor: 5.958

10.  Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake.

Authors:  S Kamel; P Fardellone; B Meddah; F Lorget-Gondelmann; J L Sebert; M Brazier
Journal:  Clin Chem       Date:  1998-07       Impact factor: 8.327

View more
  3 in total

1.  The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.

Authors:  S Alonso; E Ferrero; M Donat; G Martínez; C Vargas; M Hidalgo; E Moreno
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

Review 2.  Bone turnover in hyperparathyroidism.

Authors:  Katharina Kerschan-Schindl
Journal:  Wien Med Wochenschr       Date:  2012-07-18

3.  Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy.

Authors:  Philippe Boudou; Fidaa Ibrahim; Catherine Cormier; Emile Sarfati; Jean-Claude Souberbielle
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.